Today, the European Commission has approved, under EU State aid rules, the second health-related Important Project of Common European Interest (IPCEI) to support innovation in medical devices. “This – according to Brussels – includes the introduction of novel digital and artificial intelligence (AI) features in medical devices”. The IPCEI “will support collaborative research and innovation, as well as the first industrial deployment of these frontier technologies”. The project, called “IPCEI Tech4Cure”, was jointly notified by five Member States: Italy, France, Slovakia, Slovenia and Hungary. The Member States will provide up to €403 million in public funding, which is expected to unlock an additional €826 million in private investments. European Commission Vice-President Teresa Ribera said: “Tech4Cure will make healthcare better, faster, and cheaper. The truly innovative projects in this IPCEI will improve patient outcomes, cut healthcare costs, and enhance EU citizens’ lives. Not only that, this IPCEI creates wide ecosystem in the European healthcare sector, where breakthrough innovations are shared along the value chain. This will strengthen the entire chain in the EU and help the green transition of the medical devices’ industry”.